The 5squirrels Award for Injectable Product of the Year

Juvéderm® from Allergan Aesthetics offers healthcare professionals (HCPs) the world’s leading brand of hyaluronic acid (HA) facial fillers ,* Designed to treat volume loss for the whole face and tailor treatments to meet patients’ needs. Creating natural looking and long-lasting results. Based on patented VYCROSS™ technology, the collection allows HCPs to choose and create bespoke treatment plans for their patients. * Based on HCP tracking market research involving over 1,700 HCPs from 16 international markets.

Juvéderm® was well positioned during the last year when clinics and healthcare practitioners (HCPs) endured disrupted practice following multiple COVID-19 lockdowns. As a facial filler range only available to HCPs, Juvéderm® offers increased peace of mind to patients, many of whom rushed to seek treatment in between lockdowns that closed non-essential businesses. HCPs providing regulated medical services were able to continue to provide Juvéderm® treatments.

The Allergan Medical Institute (AMI) promotes excellence in the field of aesthetic medicine through the provision of high-quality education on facial aesthetics. Delivered through a diverse and sophisticated training curriculum led by a faculty of facial aesthetic experts, the AMI Digital Platform ran a series of Educational Digital Webinars to enable HCPs to study throughout lockdown.

Sculptra activates the body’s ability to produce it’s own collagen, restoring the skin’s structure and renewing its natural firmness. Sculptra works with the body to stimulate collagen production lost to ageing, rebuilding and reinforcing the skin’s structural foundation. Through a series of treatments, it restores the support and volume of youthful looking skin, providing results that can last up to two years. Since 1999, Sculptra has developed a robust set of scienticic data that endorses it’s efficacy, safety and patient satisfaction. Sculptra provides patients with the ingredients to activate the skin’s natural ability to produce collagen to result in a more youthful look, gradually reversing the signs of aging with a natural-looking result that lasts. Sculptra is used by the most experienced injectors at high quality clinics, enables injectors to be member of an exclusive club of experts on facial ageing, delivering advanced treatment techniques recognised by their patients. Sculptras new reconstitution protocol developed by Galderma in the last 12 months provides injector convenience that has enhanced patient comfort and improved Sculptra’s safety data.  

Restylane is globally-recognised brand which continues to grow and evolve, with over 50 million treatments now delivered worldwide. Restylane was the first non-animal HA filler to receive European approval back in 1996 and their impressive portfolio continues to grow with new product innovations frequently being brought to the market. This year Restylane celebrated its 25th anniversary, withover 50 million treatments undertaken worldwide over that timeframe. Restylane represents the gold-standard for dermal fillers with clinical efficacy, practitioner trust and patient satisfaction. Restylane is a heritage brand with a bright past and brilliant future. 

Profhilo® stabilised hybrid cooperative complexes is the first product developed with NAHYCO® technology - a unique and innovative thermal production process patented by IBSA.

A total concentration of 64mg of hyaluronic acid in a 2ml pre-filled syringe, never before reached precisely because of technological limitations.

No chemical cross-linking agents are used and the final, thermally stabilised product, Profhilo, is pure hyaluronic acid sodium salt.

Profhilo is universally recognised within the industry as third injectable treatment option for treating skin laxity alongside toxin and dermalfillers, available in the top clinics, chains as well as individual practitioners.

The efficacy of Profhilo has been widely demonstrated by numerous clinical studies.

TEOSYAL RHA is a dermal filler range developed to respect facial dynamics, with technology that will bio-mimic the behaviour and characteristics of natural HA, enabling natural-looking results. Additionally, TEOXANE’s rigorous, patented manufacturing processes enable the highest quality and safety parameters.

This scientifically proven and FDA approved range enables HCPs to determine a tailored treatment - supported by rheology that behaves according to the anatomical zone they are placed within.

• “I'm such an advocate of the RHA range because of their dynamic nature. The filler to behaves in a similar nature to my patients' native HA, ensuring a natural result both at rest and on animation."
• “An advantage of RHA is the variety of products, whatever my patients' concerns are, their needs can always be met with this range.”
• “RHA has changed my injectable style. The natural element of the filler, its scientific properties and its ability to integrate has mimicked my desire to create a natural result.”
• “Teoxane have worked wonders to offer a range of fillers that is highly efficacious and allows growth in a result driven business”
• “RHA offers variety. There’s a lot of options for tricky areas where other ranges fall short of having the perfect rheology.”

DESIRIAL® is a fluid gel designed to restore hydration, elasticity, tonicity and sensitivity to the vulvo-vaginal area. It is also used to treat vaginal dryness. DESIRIAL® is the first product in the UK market to hold the CE marking for these indications.

As the tissues in the vagina start to change, discomfort or a burning feeling may occur, as well as increased sensitivity or chronic irritation and itching, which in time may cause sores. To help counteract these symptoms, Hyaluronic Acid is injected directly into the affected area to limit dryness in the vaginal mucous and improve tissue quality.

Thanks to the IPN-Like Technology, patented since 2007 and renowned for its efficacy and tolerance, DESIRIAL® is the result of a unique cross-linking process that accurately pitches the viscoelastic properties to the nature of the vaginal tissues while remaining highly hygroscopic.
The Mannitol is an antioxidant molecule that helps limit the degradation of the gel immediately after injection for optimal results.

What is WOW fusion?

WOW fusion is an innovative micro channelling device that allows the practitioner to create bespoke skincare cocktails to improve the skin health

It is a fusion of Mesotherapy, Micro-needling and Skin Nutrition

A truly tailored signature service 

WOW fusion offers results driven tried and tested protocols via professional training and ongoing clinical and marketing support, designed to increase repeat business for clinics, achieving the WOW ethos of helping small businesses grow 

The WOW Mission - To instil self-confidence through instant luminous and healthy skin. Consistently deliver desirable and educational brand messaging to the consumer, instilling confidence in our partners to help make the world a little more #WOW.

#WOW the world and let the world #WOW you